期刊文献+

舒肝活血化痰方对非酒精性脂肪性肝炎大鼠血清瘦素、胰岛素抵抗指数的影响 被引量:4

Effect of Shugan Huoxue Huatan Decoction on Insulin Resistance in Rats with Non-alcoholic Steatohepatitis
下载PDF
导出
摘要 目的探讨舒肝活血化痰方对非酒精脂肪性肝炎大鼠胰岛素抵抗(IR)的作用。方法采用高脂饮食复制高脂血症脂肪性肝炎大鼠模型,用舒肝活血化痰方治疗,以东宝肝泰作对照,观察其对模型大鼠肝功能、血脂、肝组织羟脯氨酸(Hyp)含量、血清瘦素(LEP)和胰岛素抵抗指数(FIRI)的影响。结果舒肝活血化痰方显著改善肝功能(P<0.01或P<0.05),降低血清三酰甘油(TG)、总胆固醇(TC)及低密度脂蛋白胆固醇(LDL-C),同时升高高密度脂蛋白胆固醇(HDL-C)含量(P<0.01或P<0.05),并有显著降低肝组织Hyp含量(P<0.05)及血清LEP、FIRI(P<0.01或P<0.05)的作用。结论舒肝活血化痰方可能通过改善LEP及FIRI,抑制肝脏的脂肪贮积、减轻肝损伤和阻止脂肪性肝纤维化的发生发展。 Objective To investigate the effects of Shugan Huoxue Huatan Decoction (SHHD) on non-alcoholic steatohepatitis (NASH) of rats. Methods 32 SD male rats were randomly allocated into 4 groups: normal group, model group, Dongbao Gantai (DBG) group, SHHD group. NASH model was induced by hyperlipid diet. General condition and pathological changes of liver tissues were observed. Liver function, blood lipids, liver tissue Hyp and serum LEP were dectected. Fasting insulin resistance index (FIRI) was evaluated according to the levels of fasting blood glucose (FBG) and fasting serum insulin (FINS). Compared with model group, SHHD had the effects of improving liver function and blood lipids, decreasing liver tissue Hyp, LEP and FIRI siginificanfly. Conclusion Inhibiting leptin and insulin resistances, enhancing the lipid metabolism are probably the main mechanisms of SHHD in preventing and treating NASH.
作者 王兵 朱平生
出处 《中国中医药信息杂志》 CAS CSCD 2007年第2期39-41,共3页 Chinese Journal of Information on Traditional Chinese Medicine
基金 河南省自然科学基金(0511043400)
关键词 脂肪性肝炎 舒肝活血化痰方 胰岛素抵抗 瘦素抵抗 steatohepatitis Shugan Huoxue Huatan Decoction insulin resistance leptin resistance
  • 相关文献

参考文献6

二级参考文献17

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2雷闽湘 曹行芝 廖二元 等 见:廖二元 超楚生主编.糖尿病[A].见:廖二元,超楚生主编.内分泌学[C].北京:人民卫生出版社,2001.1434—1496.
  • 3唐炜立 超楚生 见:廖二元 超楚生主编.肝脏与内分泌[A].见:廖二元,超楚生主编.内分泌学[C].北京:人民卫生出版社,2001.2203—2208.
  • 4Marchesini G, Brizi M, Morselli Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med, 1999, 107(5) :450 - 455.
  • 5Paul A. Nonalcoholic fatty liver disease. N Engl J Med,2002,346(16) :1221 - 1231.
  • 6Mohamde,Goodrick S,Rawesh A, et al.Subcutaneous adipose tissue releases interleukin-6 but not tumor nerosis factor-α,in vivo[J].J Clin Endocrinol Metab,1997,82:4196-4200.
  • 7Zhang Y,Peoenca R,Maffei M, et al.Positional cloning of the mouse obese gene and its human homologue[J].Nature,1994,372:425-432.
  • 8Yamauchi T,Kamon J,Waki H, el al.The fatderived hormone adiponctin reverses insulin resistance associated with both lipoatrophy and obesity[J].Nat Med,2001,7:941-946.
  • 9范建高,曾民德,陈政绩,范竹萍,沈镭,李继强,邱德凯.265例脂肪肝患者病因及其特点分析[J].上海医学,1998,21(2):68-70. 被引量:103
  • 10王泰龄,刘霞,周元平,何静雯,张晶,李宁章,段钟平,王宝恩.慢性肝炎炎症活动度及纤维化程度计分方案[J].中华肝脏病杂志,1998,6(4):195-197. 被引量:388

共引文献459

同被引文献43

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部